glp 1 agonist drugs for weight loss Is GLP-1 Safe Loss? Peptides, Benefits & Risks GLP-1 Agonists: A Comprehensive Overview

Why Multi-Receptor Agonists Are a Game-Changer for Adolescent Obesity Despite the success of GLP-1 monotherapy, dual and triple agonists offer significant advantages in obesity treatment by engaging multiple hormonal pathways

doi: 10.1186/s12933-017-0626-3 128 YueWLiYOuDYangQ

Endocrinology Advisor Conclusion The 2025 GLP-1 guidelines reflect a paradigm shift in the management of type 2 diabetes, emphasizing the multifaceted benefits of these agents

Haukeland JW, Konopski Z, Eggesb HB, von Volkmann HL, Raschpichler G, Bjro K, et al

It could indicate inadequate caloric intake, nutritional deficiencies, dehydration, or rarely, an underlying condition unmasked by the metabolic changes